Medek; Ales

Patent Applications and Registrations

Patent applications and USPTO patent grants for Medek; Ales.The latest application filed is for "pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases".

Company Profile

9.15.35

Medek; Ales - Winchester MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases App 20210308053 - Phenix; Brian Dean ; et al.	2021-10-07
Solid Forms Of Apol1 Inhibitor And Methods Of Using Same App 20210246121 - LAI; Mei-Hsiu ; et al.	2021-08-12
Modulators Of Alpha-1 Antitrypsin App 20210179587 - BANDARAGE; Upul Keerthi ; et al.	2021-06-17
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases Grant 10,980,746 - Phenix , et al. April 20, 2	2021-04-20
Crystalline Forms Of Cftr Modulators App 20210047323 - Shi; Yi ; et al.	2021-02-18
Compounds Useful As Inhibitors Of Atr Kinase App 20210032255 - CHARRIER; Jean-Damien ; et al.	2021-02-04
Inhibitors Of Apol1 And Methods Of Using Same App 20200377479 - CAO; Jingrong ; et al.	2020-12-03
Modulators Of Alpha-1 Antitrypsin App 20200361939 - BANDARAGE; Upul Keerthi ; et al.	2020-11-19
Compounds useful as inhibitors of ATR kinase Grant 10,815,239 - Charrier , et al. October 27, 2	2020-10-27
Compounds Useful As Inhibitors Of Atr Kinase App 20190256516 - Charrier; Jean-Damien ; et al.	2019-08-22
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases App 20190125674 - Phenix; Brian Dean ; et al.	2019-05-02
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases Grant 10,206,877 - Phenix , et al. Feb	2019-02-19
Pharmaceutical Compositions And Administrations Thereof App 20190038615 - Van Goor; Fredrick F. ; et al.	2019-02-07
Compounds useful as inhibitors of ATR kinase Grant 10,160,760 - Charrier , et al. Dec	2018-12-25
Pharmaceutical Compositions And Administrations Thereof App 20180153874 - Van Goor; Fredrick F. ; et al.	2018-06-07
Solid forms of a thiophosphoramidate nucleotide prodrug Grant 9,856,284 - Kuldipkumar , et al. January 2, 2	2018-01-02
Inhibitors of influenza viruses replication Grant 9,771,361 - Nti-Addae , et al. September 26, 2	2017-09-26
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator Grant 9,701,639 - Strohmeier , et al. July 11, 2	2017-07-11
Solid Forms Of A Thiophosphoramidate Nucleotide Prodrug App 20160318969 - Kuldipkumar; Anuj K ; et al.	2016-11-03
Inhibitors Of Influenza Viruses Replication App 20160251353 - Nti-Addae; Kwame W. ; et al.	2016-09-01
Solid forms of a thiophosphoramidate nucleotide prodrug Grant 9,394,330 - Kuldipkumar , et al. July 19, 2	2016-07-19
Co-crystals Of Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20160096807 - Strohmeier; Mark ; et al.	2016-04-07
Pharmaceutical Compositions And Administrations Thereof App 20160067239 - Van Goor; Fredrick F. ; et al.	2016-03-10
Pharmaceutical Compositions and Administrations Thereof App 20160022665 - Van Goor; Fredrick F. ; et al.	2016-01-28
Pharmaceutical Compositions and Administrations Thereof App 20160022664 - Van Goor; Fredrick F. ; et al.	2016-01-28
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases App 20150320736 - Phenix; Brian Dean ; et al.	2015-11-12
Solid Forms Of A Thiophosphoramidate Nucleotide Prodrug App 20150175647 - Kuldipkumar; Anuj K. ; et al.	2015-06-25
Pharmaceutical Compositions And Administrations Thereof App 20150164883 - Van Goor; Fredrick F. ; et al.	2015-06-18
Pharmaceutical Compositions and Administrations Thereof App 20150164881 - Van Goor; Fredrick F. ; et al.	2015-06-18
Compounds Useful As Inhibitors Of Atr Kinase App 20150158872 - Charrier; Jean-Damien ; et al.	2015-06-11
Pharmaceutical Compositions And Administrations Thereof App 20150141459 - Van Goor; Fredrick F. ; et al.	2015-05-21
Solid forms of a thiophosphoramidate nucleotide prodrug Grant 8,916,538 - Kuldipkumar , et al. December 23, 2	2014-12-23
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20140329855 - Arekar; Sneha G. ; et al.	2014-11-06
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 8,785,476 - Arekar , et al. July 22, 2	2014-07-22
Solid Forms of a Thiophosphoramidate Nucleotide Prodrug App 20140154210 - Kuldipkumar; Anuj K. ; et al.	2014-06-05
Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(- trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide Grant 8,741,922 - Zhang , et al. June 3, 2	2014-06-03
Pharmaceutical Compositions And Administrations Thereof App 20130338188 - Van Goor; Fredrick F. ; et al.	2013-12-19
Solid Forms of a Thiophosphoramidate Nucleotide Prodrug App 20130266538 - Kuldipkumar; Anuj K. ; et al.	2013-10-10
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 8,471,029 - Arekar , et al. June 25, 2	2013-06-25
Pharmaceutical Compositions And Administrations Thereof App 20130158071 - Van Goor; Fredrick F. ; et al.	2013-06-20
Pharmaceutical Compositions And Administrations Thereof App 20130143919 - Van Goor; Fredrick F. ; et al.	2013-06-06
Solid Forms Of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(- Trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide App 20130137722 - Zhang; Beili ; et al.	2013-05-30
Pharmaceutical Compositions And Administrations Thereof App 20130131107 - Van Goor; Fredrick F. ; et al.	2013-05-23
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20130079367 - Arekar; Sneha G. ; et al.	2013-03-28
Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(- Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide Grant 8,389,727 - Zhang , et al. March 5, 2	2013-03-05
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20130018071 - Arekar; Sneha G. ; et al.	2013-01-17
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20110230519 - Arekar; Sneha G. ; et al.	2011-09-22
Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(- Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide App 20110123449 - Zhang; Beili ; et al.	2011-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.